Agata Wujkowska holds a M.Sc. degree in molecular medicine and biology. She finished Medical University in Lodz (Poland) in 2016. In her Master Thesis, she have been focused on Rho signalling pathway which was stimulated by TGF-beta and the role of this pathway in diseases induction, such as skin fibrosis. During her studies, she achived laboratory technical experienced due to collaboration with several research centers, such as Nencki Institute or CelonPharma, where she worked as a trainee. In 2016, she joined ATG:biosynthetics to work on European MycoSynVac project. She is supporting technical part of the project which is based on identification of neutralizing epitopes to design the best protective vaccine.